Related Experiment Video

Updated: Jun 17, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Parental attitudes towards overnight closed-loop glucose control in children with type 1 diabetes

Daniela Elleri1, Carlo L Acerini, Janet M Allen

  • 1Department of Paediatrics, University of Cambridge, Cambridge CB2 0QQ, United Kingdom.

Diabetes Technology & Therapeutics
|January 20, 2010
PubMed

Insights

Parents of children with type 1 diabetes (T1D) are eager for overnight closed-loop (CL) systems to manage nighttime glucose control, a significant challenge. They expressed trust in CL technology, welcoming its potential for improved diabetes management.

Area of Science:

  • Pediatric Endocrinology
  • Biomedical Engineering
  • Diabetes Technology

Background:

  • Parental attitudes towards overnight closed-loop (CL) glucose control in children with type 1 diabetes (T1D) were investigated.
  • Nighttime glucose management is a significant challenge for parents of children with T1D.

Purpose of the Study:

  • To evaluate parental acceptance and concerns regarding overnight CL glucose control systems.
  • To understand parental trust in automated insulin delivery for pediatric T1D management.

Main Methods:

  • Focus group and questionnaire-based study with 19 parents of children with T1D.
  • Families were recruited through the INsulin PUmp Therapy (INPUT) group.
  • Participants received information on CL technology and the Artificial Pancreas Project.

Main Results:

  • All parents welcomed the development of CL systems for diabetes management.
  • 95% of parents were comfortable with their child using a continuous glucose monitor and insulin pump simultaneously.
  • 90% of parents expressed no concern about a computer controlling their child's overnight insulin delivery.

Conclusions:

  • Parents of children with T1D, particularly insulin pump users, show trust in overnight CL technology.
  • Addressing nighttime glucose control challenges through CL systems is a crucial goal for improving T1D management.
  • Parental acceptance suggests a positive outlook for the adoption of CL systems in pediatric T1D care.
Abstract

More Related Videos

Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection06:11

Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection

Published on: May 17, 2024

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...